World First CAR-T Therapy for Solid Tumors

Summary China’s NMPA approved CARsgen’s satri-cel, the first CAR-T therapy approved anywhere in the world for a solid tumor. What Happened The approval covers Claudin18.2-positive advanced gastric and gastroesophageal junction cancer after at least two prior lines of therapy. Deep Analysis This is a field-defining…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *